No Data
No Data
BS, JDSP and others [Emerging Markets Press Release]
<155A>Information strategy shareholder benefits have changed the benefits items. <3623>BS upward revision, this fiscal year's operating profit forecast is 0.616 billion yen, revised from 0.489 billion yen with increased dividends; this fiscal year's year-end dividend per share is 21.50 yen, revised from 12.00 yen. <3195>Genepa has started a new business (Unique Stores Platform business). <3674>Oukfan has completed the acquisition of its own shares. <3777>Environment-friendly ACSL has entered into a business alliance. <4054>Japan Information C System is involved in Software Development.
Fisco etc [stocks with enticing potential from the perspective of volume changes]
Stock closing price compared to the previous day volume *<3840> Pass 11,964,249,300 *<6696> Trance OP 402,453,949,000 *<7082> Jimoty 125,715,192,400 *<3181> Buy King 70,569,111,500 *<3807> Fisco 1,603,631,203,600 *<9439> MH Group 1,942,165,400 *<6634> Nex Group 1,096,431,6200 *<9824> Senshu Denki 562,036,038,1200 *<2
Subdued, with a strong upward trend in long-term US interest rates, among other heavy factors.
[Emerging Markets Individual Stock Global Strategy] Today's emerging markets are expected to experience a weak performance. In the U.S. stock market on the 13th, the dow inc rose slightly by 47.21 points (+0.11%) to 43,958.19 dollars. There was an initial buying sentiment due to the consumer price index (CPI) for October matching financial estimates. At the same time, as a result of the CPI, expectations for additional interest rate cuts at the Federal Open Market Committee (FOMC) in December intensified, leading to a continued rise in the market. While the dow inc remained strong throughout the day, the nasdaq slowed down towards the end.
Information Strategy and Technology: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/12
Information Strategy and Technology: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Deere & Co, RepliCel, and others [Emerging Markets Press Release]
Following the company split (simplified establishment split) at <155A>, a subsidiary was established. At <3935>, deere & co requested a market change to the Tokyo Stock Exchange's standard market. At <4978>, Cell AMED received approval for the market change. The grant amount for the 2023 fiscal year for the Public Offering Business 'Basic Technology Development Project for Industrialization of Regenerative Medicine and Gene Therapy' has been determined.